Residual HIV-1 disease in the era of highly active antiretroviral therapy

被引：32

作者：

Pomerantz, RJ ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1999年 / 340卷 / 21期

关键词：

D O I：

10.1056/NEJM199905273402110

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1672 / 1674

页数：3

共 21 条

[1]

Cavert W, 1997, SCIENCE, V276, P1321

[2] Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].

Cavert, W ;

Notermans, DW ;

Staskus, K ;

Wietgrefe, SW ;

Zupancic, M ;

Gebhard, K ;

Henry, K ;

Zhang, ZQ ;

Mills, R ;

McDade, H ;

Goudsmit, J ;

Danner, SA ;

Haase, AT .

SCIENCE, 1997, 276 (5314) :960-964

[3] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[4] Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J].

Chun, TW ;

Engel, D ;

Berrey, MM ;

Shea, T ;

Corey, L ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8869-8873

[5]

CHUN TW, 1999, 6 C RETR OPP INF CHI, P160

[6] Target cell availability and the successful suppression of HIV by hydroxyurea and didanosine [J].

De Boer, RJ ;

Boucher, CAB ;

Perelson, AS .

AIDS, 1998, 12 (13) :1567-1570

[7] Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].

Finzi, D ;

Blankson, J ;

Siliciano, JD ;

Margolick, JB ;

Chadwick, K ;

Pierson, T ;

Smith, K ;

Lisziewicz, J ;

Lori, F ;

Flexner, C ;

Quinn, TC ;

Chaisson, RE ;

Rosenberg, E ;

Walker, B ;

Gange, S ;

Gallant, J ;

Siliciano, RF .

NATURE MEDICINE, 1999, 5 (05) :512-517

[8] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].

Finzi, D ;

Hermankova, M ;

Pierson, T ;

Carruth, LM ;

Buck, C ;

Chaisson, RE ;

Quinn, TC ;

Chadwick, K ;

Margolick, J ;

Brookmeyer, R ;

Gallant, J ;

Markowitz, M ;

Ho, DD ;

Richman, DD ;

Siliciano, RF .

SCIENCE, 1997, 278 (5341) :1295-1300

[9] Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].

Furtado, MR ;

Callaway, DS ;

Phair, JP ;

Kunstman, KJ ;

Stanton, JL ;

Macken, CA ;

Perelson, AS ;

Wolinsky, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622

[10] Control of HIV despite the discontinuation of antiretroviral therapy [J].

Lisziewicz, J ;

Rosenberg, E ;

Lieberman, J ;

Jessen, H ;

Lopalco, L ;

Siliciano, R ;

Walker, B ;

Lori, F .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1683-1684

← 1 2 3 →